Measuring drug exposure: Concordance between defined daily dose and days' supply depended on drug class

Journal of Clinical Epidemiology

Volumn 69, Issue , 2016, Pages 107-113

  Sinnott, Sarah Jo ^a,c   Polinski, Jennifer M ^b   Byrne, Stephen ^a   Gagne, Joshua J ^b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c ECONOMIC AND SOCIAL RESEARCH INSTITUTE   (Ireland)

Author keywords

Bias (epidemiology); Daily defined dose; Drug exposure; Medicaid; Pharmacoepidemiology; Prescription drugs supply

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CYCLOOXYGENASE 2 INHIBITOR; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; METFORMIN; NONSTEROID ANTIINFLAMMATORY AGENT; PRESCRIPTION DRUG; PROTON PUMP INHIBITOR; WARFARIN;

ADULT; ARTICLE; CLINICAL PHARMACY; DEFINED DAILY DOSE; DRUG DAYS SUPPLY; DRUG EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAID; MIDDLE AGED; PHARMACEUTICAL CARE; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; UNITED STATES; COHORT ANALYSIS; DRUG ADMINISTRATION; DRUG THERAPY; FACTUAL DATABASE; PRESCRIPTION; STATISTICS AND NUMERICAL DATA; TIME FACTOR;

ADULT; COHORT STUDIES; DATABASES, FACTUAL; DRUG ADMINISTRATION SCHEDULE; DRUG PRESCRIPTIONS; DRUG THERAPY; FEMALE; HUMANS; MALE; MIDDLE AGED; TIME FACTORS;

EID: 84952629596     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2015.05.026     Document Type: Article

References (23)

1. J.T. Lessler, and B.S.H. Harris Medicaid data as a source for Postmarketing Surveillance information Technical Report Volume 1 1984 Research Triangle Inst Research Triangle Park, NC
2. R. Tamblyn, G. Lavoie, L. Petrella, and J. Monette The use of prescription claims databases in pharmacoepidemiological research: the accuracy and comprehensiveness of the prescription claims database in Québec J Clin Epidemiol 48 1995 999 1009
3. B. Wettermark, H. Zoega, K. Furu, M. Korhonen, J. Hallas, M. Nørgaard, and et al. The Nordic prescription databases as a resource for pharmacoepidemiological research - a literature review Pharmacoepidemiol Drug Saf 22 2013 691 699
4. T. Grimes, M. Fitzsimons, M. Galvin, and T. Delaney Relative accuracy and availability of an Irish National Database of dispensed medication as a source of medication history information: observational study and retrospective record analysis J Clin Pharm Ther 38 2013 219 224
5. R. Gross, W.B. Bilker, B.L. Strom, and S. Hennessy Validity and comparison of two measures of days supply in Medicaid claims data Pharmacoepidemiol Drug Saf 17 2008 1029 1032
6. J. Merlo, A. Wessling, and A. Melander Comparison of dose standard units for drug utilisation studies Eur J Clin Pharmacol 50 1996 27 30
7. M. Qvarnström, T. Kahan, H. Kieler, L. Brandt, J. Hasselström, K.B. Boström, and et al. Persistence to antihypertensive drug treatment in Swedish primary healthcare Eur J Clin Pharmacol 69 2013 1955 1964
8. World Health Organisation Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs. Accessed at http://www.whocc.no/atc-ddd-publications/atc-ddd-index/. Accessed June 23, 2015.
9. W.D. Hall, A. Mant, P.B. Mitchell, V.A. Rendle, I.B. Hickie, and P. McManus Association between antidepressant prescribing and suicide in Australia, 1991-2000: trend analysis BMJ 326 2003 1008
10. C.R. Dormuth, R.J. Glynn, P. Neumann, M. Maclure, A.M. Brookhart, and S. Schneeweiss Impact of two sequential drug cost-sharing policies on the use of inhaled medications in older patients with chronic obstructive pulmonary disease or asthma Clin Ther 28 2006 964 978 discussion 962-3
11. J.J. Gagne, V. Maio, and C. Rabinowitz Prevalence and predictors of potential drug-drug interactions in Regione Emilia-Romagna, Italy J Clin Pharm Ther 33 2008 141 151
12. S. Geisel-Marbaise, and H. Stummer Diabetes adherence - does gender matter? J Public Health 18 2010 219 226
13. S. Daniel, G. Koren, E. Lunenfeld, N. Bilenko, R. Ratzon, and A. Levy Fetal exposure to nonsteroidal anti-inflammatory drugs and spontaneous abortions Can Med Assoc J 186 2014 E177 E182
14. The Kaiser Family Foundation. The Medicaid program at a glance. Accessed at http://kaiserfamilyfoundation.files.wordpress.com/2013/03/7235-061.pdf. Accessed June 23, 2015.
15. W.A. Ray Evaluating medication effects outside of clinical trials: new-user designs Am J Epidemiol 158 2003 915 920
16. WHO Collaborating Centre for Drug Statistics Methodology. Guidelines for ATC classification and DDD assignment 2015. Oslo. Accessed at http://www.whocc.no/filearchive/publications/2015-guidelines.pdf. Accessed June 23, 2015.
17. D. Lee, and U. Bergman Studies of drug utilisation B.L. Strom, Pharmacoepidemiology Chapter 29, 3rd edn. 2000 John Wiley & Sons Chichester, UK
18. F.M. Arellano, M.U. Yood, C.E. Wentworth, S.A. Oliveria, E. Rivero, A. Verma, and et al. Use of cyclo-oxygenase 2 inhibitors (COX-2) and prescription non-steroidal anti-inflammatory drugs (NSAIDS) in UK and USA populations. Implications for COX-2 cardiovascular profile Pharmacoepidemiol Drug Saf 15 2006 861 872
19. B.T. Vanderhoff, and R.M. Tahboub Proton pump inhibitors: an update Am Fam Physician 66 2002 273 280
20. S. Vegter, N.H. Nguyen, S.T. Visser, L.T. de Jong-van den Berg, M.J. Postma, and C. Boersma Compliance, persistence, and switching patterns for ACE inhibitors and ARBs Am J Manag Care 17 2011 609 616
21. G. Dailey, M.S. Kim, and J.F. Lian Patient compliance and persistence with antihyperglycemic drug regimens: evaluation of a medicaid patient population with type 2 diabetes mellitus Clin Ther 23 2001 1311 1320
22. R.E. Polk, C. Fox, A. Mahoney, J. Letcavage, and C. MacDougall Measurement of adult antibacterial drug use in 130 US hospitals: comparison of defined daily dose and days of therapy Clin Infect Dis 44 2007 664 670
23. S. Schneeweiss, and J. Avorn A review of uses of health care utilization databases for epidemiologic research on therapeutics J Clin Epidemiol 58 2005 323 337